[{"NetIncomeLoss_1_Q2_USD":-11331000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":3157387.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":3164707.0,"DueFromRelatedPartiesCurrent_0_Q2_USD":527000.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_2_Q2_USD":-6.78,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q2_USD":-4.41,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestPaidNet_2_Q2_USD":188000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-10000.0,"PurchaseObligation_0_Q2_USD":6372000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-434000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-219000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":247000.0,"AssetsCurrent_0_Q2_USD":100664000.0,"OperatingLeaseExpense_2_Q2_USD":400000.0,"OperatingLeaseExpense_1_Q2_USD":200000.0,"LongTermDebt_0_Q2_USD":6964000.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":641000.0,"LongTermDebtCurrent_0_Q2_USD":1714000.0,"CostsAndExpensesRelatedParty_2_Q2_USD":1075000.0,"CostsAndExpensesRelatedParty_1_Q2_USD":479000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":175043000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":25309789.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":577000.0,"CommonStockSharesIssued_0_Q2_shares":3166946.0,"IncreaseDecreaseInDeferredLiabilities_2_Q2_USD":-135000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3172000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":4645000.0,"DepreciationAndAmortization_1_Q2_USD":100000.0,"DepreciationAndAmortization_2_Q2_USD":200000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":11491000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":7663000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1657000.0,"TemporaryEquityLiquidationPreference_0_Q2_USD":193220000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":21461756.0,"PurchaseObligationDueInSecondYear_0_Q2_USD":298000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":24000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":20000.0,"PurchaseObligationDueInNextTwelveMonths_0_Q2_USD":1563000.0,"PreferredStockDividendsIncomeStatementImpact_2_Q2_USD":4624000.0,"PreferredStockDividendsIncomeStatementImpact_1_Q2_USD":2641000.0,"CommonStockValue_0_Q2_USD":3000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":192000.0,"Assets_0_Q2_USD":103112000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":104222000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"IncreaseDecreaseInDueFromRelatedPartiesCurrent_2_Q2_USD":-9000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q2_USD":358000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":4140000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-21409000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-13972000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2003000.0,"OtherAssetsNoncurrent_0_Q2_USD":2411000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":98103000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":5166000.0,"Liabilities_0_Q2_USD":12467000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":1100000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":273000.0,"ShareBasedCompensation_2_Q2_USD":3004000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":3743000.0,"PreferredStockDividendsAndOtherAdjustments_2_Q2_USD":4624000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q2_USD":2641000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":92000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":214000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-16761000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-11311000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2853000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-15126000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":3157387.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":3164707.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":560000.0,"LiabilitiesCurrent_0_Q2_USD":7719000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":89086000.0,"AccountsPayableCurrent_0_Q2_USD":1865000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":98103000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1393000.0,"LongTermDebtNoncurrent_0_Q2_USD":3928000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":301000.0,"InterestExpenseDebt_2_Q2_USD":400000.0,"InterestExpenseDebt_1_Q2_USD":200000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":3007000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1953000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":36228000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":37000.0,"NetIncomeLoss_2_Q2_USD":-16785000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":3166946.0,"AssetImpairmentCharges_1_Q2_USD":0.0,"AssetImpairmentCharges_2_Q2_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1137000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":1519618271.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1182000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":527000.0,"OperatingIncomeLoss_2_Q2_USD":-16029000.0,"OperatingIncomeLoss_1_Q2_USD":-10787000.0,"OtherNonoperatingExpense_2_Q2_USD":298000.0,"OtherNonoperatingExpense_1_Q2_USD":305000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":103112000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":671000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3004000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":25417750.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2853000.0,"OperatingExpenses_2_Q2_USD":17211000.0,"OperatingExpenses_1_Q2_USD":11314000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-6.78,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-4.41,"ProfitLoss_2_Q2_USD":-16785000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":820000.0,"DeferredOfferingCosts_0_Q2_USD":2411000.0,"StockholdersEquity_0_Q2_USD":-84398000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":4511000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":10000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":6000000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":221000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-89567000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":129000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2219000.0,"Ticker":"ALXO","CIK":"1810182","name":"ALX ONCOLOGY HOLDINGS INC","OfficialName":"ALX Oncology Holdings Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"632216571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200827"}]